top of page

Your automated

Screen Shot 2023-01-24 at 10.51.43 AM.png

  disinfection technology.

Brought to you by


The only patented,hospital-grade
surface disinfecting system approved for fogging
EPA-registered Hypochlorous acid (HOCl).

Reaches 100% of surfaces and room air

Immediate room re-entry

ZERO pathogen transfer and human variability

Delivers LOG 4-6 EPA registered efficacy

Cloud-based data and reporting

Video Overview
nimbus logo Blue Orange Dot_Original Nimbus.png


The New Evolution of Whole Room Disinfection.

Ultra-fine HOCl atomization (fogging) technology

Ensures 100% room surface and air contact 

No  shadowing

Automated Technology

Hands free with no monitoring or repositioning

Eliminates pathogen transfer

Dehumidification and air scrubbing technology

Rapidly removes fog and moisture from room

Safe for immediate room re-entry

Anchor 1

Nevoa’s proprietary
Hypochlorous Acid solution

No Shelf life due to patented mixing cap  
Microburst cap_edited_edited_edited_edit

pH neutral – less corrosive than bleach

Environmentally safe and responsible

Bar-coded for quality control and data tracking

Microburst Disinfection

FDA considers HOCl to be:

…the form of free available chlorine having the highest bactericidal activity against a broad range of microorganisms… U.S.FDA,2015

Read our blog

Learn what's happening in the world of hospital disinfection - from industry updates and the new evolution of advanced disinfection to all kinds of tips and insights.

Greater than
against pathogens
on surfaces and room air.

Independent Study Results

staphylococcus aureus2 - 1000_F_19533423_XwH0ec9xUHLpyRUCkZKpMcChhEjUlA19.jpg

Staphylococcus aureus

Gram-positive bacteria.

Tested with soil load,

ATCC #6538.

Average results:

6.5 Log10 reduction

Pseudomonas aeruginosa - 1000_F_296936119_zE4e5ytNAYUmLIkseJQyBOj7jz9NP2XF.jpg

Pseudomonas aeruginosa

Gram-negative bacteria

(MDRO).Tested with soil

load, ATCC #15442.

Average results:

6.5 Log10 reduction

Influenza A - 1000_F_177983924_AugXRnWoZP05YvzFC3WbTshRPUwIHPpI_edited.jpg

Influenza A

Enveloped virus.

Tested with soil load,

10 min. contact,

ATCC #VR-1469.

Average results:

4.8 Log10 reduction

Streptococcus faecalis - -1000_F_324170691_PEOCi4Xa4aS1pXYLz0XukoN8m8XeIVrX.jpg

Vancomycin-resistant ebericiccys

(VRE) enerococcus faecalis

Gram-positive bacteria (MDRO).

Tested without soil load,

ATCC #51575.

Average results:

5.6 Log10 reduction

Human Rhinovirus2 - 1000_F_352575655_oFzxvIOnu8tyI2vORntpARUbRuGwlkiP.jpg

Human Rhinovirus

Non-enveloped virus. Tested

with soil load,1 min. contact,

ATCC #VR-283,

Strain 11757.

Average results:

4.8 Log10 reduction

norovirus - 1000_F_191867357_ndj8oxkBt9ejLESbbumoTIiPtbpRkHtO.jpg


Non-enveloped virus, EPA

recognized surrogate for Human Norovirus. Tested with soil

load,1 min. contact,

ATCC #VR-782,Strain F-9.

Average results:

5.2 Log10 reduction

Salmonella enterica2- 1000_F_457178437_Iwcz6laYv6zgNoyjCfnEI5dixJpTvDYF.jpg

Salmonella enterica

Gram-negative bacteria.

Tested with soil load,

ATCC #10708.

Average results:

6.4 Log10 reduction

Staphylococcus aeruginosa- 1000_F_101448740_bWWsKXAKddmXYRE6f8kr1WPsLP3ydvZ5.jpg

Methicilin - resistant

Staphylococcus aureus  MRSA

Gram-positive bacteria (MDRO).

Tested with and without soil

load, ATCC #33592.

Average results:

4.8 Log10 reduction

Hover to see study results

Escherichia coli - 1000_F_32769654_9PTE0epfQBYclGEy7FZmMM5G6LwrWnPW.jpg

Escherichia coli

Gram-negative bacteria.

Tested without soil load,

ATCC #15597.

Average results:

4.0 Log10 reduction

Candida Auris2-1000_F_219138736_d7wmfoicNGgZICjxufadhLgUa3vhkHRD.jpg

Candida auris

Fungus (MDRO) identified in

2009.Tested with soil load,

2 min. contact,CDC Strain


Average results:

4.8 Log10 reduction

Clostridium difficile2-1000_F_273530159_pUg5tZdhC3Yahi5JaPxImppqB1eGzZ0e.jpg

Clostridium difficile

Gram-positive bacterial

spore (MDRO). Tested against spores with  soil load, 10 min. contact,

ATCC #43598.

Average results:

5.9 Log10 reduction


Percent of Pathogen Reduction

Final percent reduction chart for web 11292021-01.png
Anchor 2

EPA Registered
Hospital Grade Disinfection

EPA Protocol

The EPA protocol for fogging device testing states that target(test) microorganisms must be placed in 20 different locations within the room (ceilings, walls, floors, under tables, etc.) to ensure the disinfectant is reaching ALL surfaces and is at least 99.99% effective at all locations.

EPA registration as a hospital-grade disinfectant required antimicrobial performance testing against

three primary microorganisms: S. aureus, S. enterica,

and P. aeruginosa. These three microorganisms were tested at each of the 20 room locations in triplicate

for a total of 180 total in-vitro samples.

Our nimbus achieves 
disinfection than manual
cleaning alone.

  Research Publication

Impact of a Whole-Room

Atomizing Disinfection System on Healthcare Surface Contamination,

Pathogen Transfer, and Labor Efficiency

Key Findings
Hi Rez Test Tube- AdobeStock_49614253.jpeg

Reynolds K: Critical Care Explorations. February 2021,

Volume 3, Number 2

300X better disinfection than manual cleaning alone  

64% less labor for terminal cleaning

Zero pathogen transfer

30-minutes of labor gained for reallocation

Efficiencies Gained

Jan 9th 2022- 10 HRS Labor Saved_Jan 9th 2022 Revised slide.png
Jan 9th 2022 - Saving 30 mins_Jan 9th 2022 Final Slide.png
New Landing bg.png
Request a live demo from a product specialist!

*Required Field

Information provided will never be used by anyone outside of Nevoa and will never be sold to a third party.

A confirmation email will be sent and you will be brought to the home page.

Our Mission Is Clear


Nevoa was created to tackle a major problem that

few outside of the healthcare environment are

aware of. Healthcare Acquired Infections (HAIs) are

the 5th leading cause of death in the United States.

One out of 25 patients get an infection they didn’t

have when they were admitted to a hospital.HAIs

cause up to 100,000 deaths and exceed $45 Billion

in direct medical cost each year. Despite the

incredible efforts taken by hospital teams, these infections continue to be a problem. Nevoa believes

the answer is technology based solutions that

automate disinfection. Nevoa’s mission is to

transform the healthcare industry’s decades-old

manual disinfection and cleaning practices to

highly effective, automated protocols that provide superior disinfection at a reduced overall cost.


While other “whole room” disinfection technologies exist, they all come with significant shortcomings.

Some cannot sufficiently reach pathogens on every surface in a room – including difficult corners or behind and underneath furniture and equipment.

Other options use much more corrosive chemicals

that also require hours before you can safely

re-enter the room.The combination of the Nimbus Technology with Microburst Solution effectively

tackles the issue of HAIs while addressing the short comings of other whole-room disinfection




The Nevoa leadership team brings decades of experience

from a diverse array of backgrounds.Together they have

created a culture that encourages ideas, inspires passion,

and rewards hard work.They know that Nevoa brings a much needed and technologically advanced solution that will improve the lives of millions.


Press Releases

Press Release

Nevoa Inc.
Martin McGonagle as

EIN Presswire Logo.png
Press Release_edited.jpg
Press Release

Partnership between
Nevoa and LEAF Offers
Flexibility to Acquire
Nevoa’s Disinfection Robot

EIN Presswire Logo.png
bottom of page